Galleri should have a good chance to win FDA marketing approval in early 2027. But insurance coverage and widespread adoption ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), and its subsidiary, Volition Veterinary Diagnostics Development LLC, in line with their corporate social responsibility strategy announces ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

An MCED blood test increased screenable cancer detection more than 7-fold when added to the US Preventive Services Task Force (USPSTF) A/B recommended screening.

Gretchen Dirnberger shares how her current treatment for colon cancer has prompted her to share her story to help others talk ...

During a live event, Lori Wirth, MD, discussed next steps for treating a patient with progressive, radioactive ...

The Pink Army 5K is one of the most visible examples of AdventHealth’s not-for-profit mission in Flagler County. Annual philanthropic gifts and community partnerships expand access to care, ensuring ...

A teen has received a grim cancer diagnosis after a lump in his neck was initially mistaken for tonsillitis. Tyler Hemming ...

A new centre at Newcastle University will see a world-leading firm produce potentially life-saving material that helps to ...

Mass General Brigham AI and the University of Wisconsin–Madison will help to refine the company's latest foundational MRI ...

Dear Dr. Roach: I am a healthy 69-year-old female. I walk every day and belong to an exercise group that I attend twice a ...

Telix Pharmaceuticals Ltd (ASX: TLX) shares could be destined to deliver outsized returns for investors over the next 12 ...